Hyderabad-based Biological E is planning to manufacture 60 crore doses of Johnson & Johnson COVID-19 vaccine a year, according to a Reuters report. In August, Biological E had entered into an agreement with one of the Janssen Pharmaceutical companies of Johnson & Johnson for the manufacturing of the vaccine candidate.
No fresh coronavirus deaths were recorded in the national capital on the evening on Tuesday after a gap of about nine months while 100 fresh cases were registered with the Arvind Kejriwal government asserting that "Delhi's collective will is gradually winning over the infection".
Tune in to the Coronavirus Essential podcast for more.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.